Buttonwood Financial Advisors Inc. Decreases Stake in The Procter & Gamble Company (NYSE:PG)

Buttonwood Financial Advisors Inc. reduced its stake in The Procter & Gamble Company (NYSE:PGFree Report) by 5.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 9,249 shares of the company’s stock after selling 516 shares during the quarter. Buttonwood Financial Advisors Inc.’s holdings in Procter & Gamble were worth $1,355,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently modified their holdings of PG. Moneta Group Investment Advisors LLC raised its position in Procter & Gamble by 96,526.4% during the 4th quarter. Moneta Group Investment Advisors LLC now owns 38,535,557 shares of the company’s stock worth $5,840,449,000 after buying an additional 38,495,676 shares during the last quarter. Norges Bank purchased a new position in Procter & Gamble during the 4th quarter worth approximately $3,752,321,000. Morgan Stanley raised its position in Procter & Gamble by 12.6% during the 4th quarter. Morgan Stanley now owns 44,320,700 shares of the company’s stock worth $6,717,246,000 after buying an additional 4,959,527 shares during the last quarter. Barclays PLC increased its holdings in shares of Procter & Gamble by 118.1% during the 2nd quarter. Barclays PLC now owns 6,334,342 shares of the company’s stock valued at $961,170,000 after purchasing an additional 3,429,929 shares in the last quarter. Finally, Wellington Management Group LLP increased its holdings in shares of Procter & Gamble by 9.4% during the 3rd quarter. Wellington Management Group LLP now owns 35,608,913 shares of the company’s stock valued at $5,193,916,000 after purchasing an additional 3,047,557 shares in the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Stock Down 1.1 %

NYSE PG opened at $160.47 on Tuesday. The firm has a market cap of $377.59 billion, a PE ratio of 26.88, a P/E/G ratio of 3.31 and a beta of 0.44. The Procter & Gamble Company has a 52 week low of $141.45 and a 52 week high of $163.14. The business’s fifty day simple moving average is $158.99 and its 200-day simple moving average is $152.28. The company has a quick ratio of 0.44, a current ratio of 0.64 and a debt-to-equity ratio of 0.48.

Procter & Gamble (NYSE:PGGet Free Report) last issued its quarterly earnings data on Tuesday, January 23rd. The company reported $1.84 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.70 by $0.14. The firm had revenue of $21.44 billion for the quarter, compared to analyst estimates of $21.48 billion. Procter & Gamble had a net margin of 17.60% and a return on equity of 34.04%. Procter & Gamble’s revenue was up 3.2% on a year-over-year basis. During the same period in the previous year, the firm earned $1.59 EPS. As a group, equities analysts anticipate that The Procter & Gamble Company will post 6.45 earnings per share for the current year.

Procter & Gamble Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, February 15th. Investors of record on Friday, January 19th were issued a $0.9407 dividend. The ex-dividend date of this dividend was Thursday, January 18th. This represents a $3.76 annualized dividend and a yield of 2.34%. Procter & Gamble’s dividend payout ratio (DPR) is currently 62.98%.

Analysts Set New Price Targets

PG has been the subject of several recent research reports. Barclays lifted their target price on shares of Procter & Gamble from $160.00 to $165.00 and gave the company an “overweight” rating in a report on Thursday, January 25th. The Goldman Sachs Group initiated coverage on shares of Procter & Gamble in a report on Friday, March 1st. They set a “neutral” rating and a $168.00 target price for the company. Stifel Nicolaus lifted their price target on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a research note on Wednesday, January 24th. UBS Group lifted their price target on shares of Procter & Gamble from $172.00 to $178.00 and gave the company a “buy” rating in a research note on Wednesday, January 24th. Finally, Raymond James lifted their price target on shares of Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a research note on Wednesday, January 24th. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $168.41.

Get Our Latest Stock Report on PG

Insider Activity at Procter & Gamble

In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the sale, the chief executive officer now directly owns 4,859 shares in the company, valued at $768,256.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, CEO R. Alexandra Keith sold 776 shares of the business’s stock in a transaction dated Monday, March 4th. The stock was sold at an average price of $158.11, for a total transaction of $122,693.36. Following the completion of the transaction, the chief executive officer now directly owns 4,859 shares of the company’s stock, valued at $768,256.49. The sale was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Marc S. Pritchard sold 101,704 shares of the business’s stock in a transaction dated Wednesday, January 24th. The stock was sold at an average price of $153.57, for a total value of $15,618,683.28. Following the transaction, the insider now directly owns 163,428 shares of the company’s stock, valued at $25,097,637.96. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 279,063 shares of company stock worth $43,187,745. Company insiders own 0.17% of the company’s stock.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.